since the last uds visit, is new information available concerning the participant's experience of amyloid related imaging abnormalities-edema (aria-e), amyloid related imaging abnormalities-hemorrhage (aria-h), or other major adverse events associated with treatments expected to modify adrd biomarkers?

Draft
Variable: Domain: Treatment Source Data Element: 3a. Since the last UDS visit, is new information available concerning the participant's experience of amyloid related imaging abnormalities-edema (ARIA-E), amyloid related imaging abnormalities-hemorrhage (ARIA-H), or other major adverse events associated with treatments expected to modify ADRD biomarkers?
Back

CDE Summary

Quick facts
Short Code
-
Domain
Treatment
Source Data Element
3a. Since the last UDS visit, is new information available concerning the participant's experience of amyloid related imaging abnormalities-edema (ARIA-E), amyloid related imaging abnormalities-hemorrhage (ARIA-H), or other major adverse events associated with treatments expected to modify ADRD biomarkers?
Data Type
-
Unit
-
Source System
NACC_csv
Permissible Values
-

Definition

No definition provided.

Notes

No notes.

Permissible Values

No permissible values specified.